- Innovation academy presentation
- Open Access
Development of antimicrobial peptides for catheter-related bloodstream infectionprevention
© Camesano et al; licensee BioMed Central Ltd. 2015
- Published: 16 June 2015
- Antimicrobial Peptide
- Central Venous Catheter
- Polyethylene Glycol
- Bloodstream Infection
- Antibacterial Resistance
Central venous catheters are used in many medical procedures to deliver critical and lifesaving treatments, such as antibiotics and chemotherapy agents. However, central line-associated bloodstream infections (CLABSIs) associated with these devices negatively impact over 100,000 patients per year and are extremely expensive to treat.
When infections arise on implanted biomaterials, they are treated with systemic antibiotics, debridement, and implant removal. Unfortunately, the high local antibiotic concentrations needed to kill colonized bacteria are only achieved over a short time, cause cytotoxicity, and can promote antibacterial resistance. Therefore, it is currently believed that proactive methods of infection management will be superior to reactive methods.
As an alternative to traditional antibiotics or to device removal, antimicrobial peptides (AMPs) represent a novel way to prevent and treat infections. AMPs are short, cationic molecules found naturally in the innate immune systems of many species, and they have broad spectrum antimicrobial activity. AMPs use fundamentally different mechanisms to kill bacteria than conventional antibiotics, reducing the threat of bacterial resistance.
The objective of our overall research program is to improve biomedical devices using a therapy based on surface-tethered AMPs. Although AMPs are highly active against bacteria when free in solution, immobilization of AMPs to a surface significantly reduces antimicrobial activity.
Antimicrobial peptides are tethered to biomaterial surfaces using flexible chemical linkers. We are currently investigating the role of the linker size in influencing the efficacy of the antimicrobial peptide. Activity against Gram-negative and Gram-positive bacteria is being quantified. We are also studying the cytotoxicty and long-term stability of the tethered peptides.
We have shown that modified antimicrobial peptide, chrysophsin-1, can be chemically tethered to a biomaterial surface using polyethylene glycol as a spacer. Killing was observed for Staphylococcus aureus and Escherichia coli.
The expected outcome of this project is a surface modification on catheters can be used to help mitigate catheter-related bloodstream infections.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.